Detalhe da pesquisa
1.
Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up.
Clin Gastroenterol Hepatol
; 14(10): 1481-1489.e5, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26872398
2.
Virological and serological tools to optimize the management of patients with chronic hepatitis B.
Liver Int
; 36 Suppl 1: 78-84, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26725902
3.
Impact of treatment against hepatitis C virus on overall survival of naive patients with advanced liver disease.
Antimicrob Agents Chemother
; 59(2): 803-10, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403673
4.
Serum Levels of Hepatitis B Surface Antigen Predict Severity of Fibrosis in Patients With E Antigen-Positive Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 13(8): 1532-9.e1, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25542306
5.
Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C.
J Virol
; 88(11): 6394-402, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24672032
6.
HBsAg quantification to optimize treatment monitoring in chronic hepatitis B patients.
Liver Int
; 35 Suppl 1: 82-90, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25529092
7.
Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.
Liver Int
; 35(9): 2082-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25612083
8.
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.
Antimicrob Agents Chemother
; 58(9): 5332-41, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24982076
9.
HBsAg quantification: useful for monitoring natural history and treatment outcome.
Liver Int
; 34 Suppl 1: 97-107, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24373085
10.
Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients.
J Hepatol
; 58(6): 1089-95, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23369792
11.
The role of HBsAg quantification for monitoring natural history and treatment outcome.
Liver Int
; 33 Suppl 1: 125-32, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23286856
12.
IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.
J Hepatol
; 56(3): 527-32, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21951981
13.
Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C.
Liver Int
; 32(4): 612-21, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22103765
14.
Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G.
Liver Int
; 32(1): 93-101, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22097898
15.
Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.
J Hepatol
; 55(5): 1121-31, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21718667
16.
Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.
Hepatology
; 51(4): 1122-6, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20069649
17.
In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C.
J Pathol
; 221(3): 264-74, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20527020
18.
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis.
J Hepatol
; 52(5): 652-7, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20346533
19.
Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients.
Hepatology
; 49(4): 1151-7, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19115222
20.
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study.
J Hepatol
; 50(6): 1084-92, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19376603